MiNK Therapeutics, Inc.
What this means
- Stockholders’ deficitAt the end of 2025 stockholders’ equity was negative: −$14.2M (XBRL data filed with the SEC).
- Net loss in 2025Net loss of $12.5M for the year (2024: −$10.8M).
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Net income (loss) | −$12.5M | −$10.8M |
| Total assets | $14.2M | $5.7M |
| Stockholders’ equity | −$14.2M | −$19.6M |
| Cash and equivalents | $13.4M | $4.6M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.
- Name as filed
- MiNK Therapeutics, Inc.
Formerly: AgenTus Therapeutics, Inc. - CIK
- 0001840229
- Tickers
- INKT
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company; Emerging growth company - Status
- Filing with the SEC
- State of incorporation
- Delaware
- Industry (SIC)
- 2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing → - Fiscal year ends
- December 31
- Last annual report
- 10-K for the period ended Dec 31, 2025
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 12, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 2.02 · filed Aug 13, 2026 · filing
- Form 10-Q · filed Aug 13, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed May 15, 2026 · filing
- Form 10-Q · filed May 15, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 31, 2026 · filing
- Form 10-K · filed Mar 31, 2026 · filing
- Form 8-K · items 5.02 · filed Mar 19, 2026 · filing
- Form 8-K · items 5.02 · filed Jan 2, 2026 · filing
- Form 8-K · items 2.02, 9.01 · filed Dec 8, 2025 · filing
- Form 10-Q · filed Nov 14, 2025 · filing
- Form 8-K · items 5.02, 9.01 · filed Sep 29, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 14, 2025 · filing
- Form 10-Q · filed Aug 14, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed May 15, 2025 · filing
- Form 10-Q · filed May 15, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 18, 2025 · filing
- Form 10-K · filed Mar 18, 2025 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 14, 2024 · filing
- Form 10-Q · filed Nov 14, 2024 · filing
- Form 8-K · items 5.02, 9.01 · filed Oct 31, 2024 · filing
- Form 8-K · items 5.02 · filed Oct 18, 2024 · filing
- Form 8-K · items 3.01 · filed Sep 13, 2024 · filing
- Form 8-K · items 3.01 · filed Aug 30, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 13, 2024 · filing
- Form 10-Q · filed Aug 13, 2024 · filing
- Form 10-Q · filed May 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed May 14, 2024 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 21, 2024 · filing
- Form 10-K · filed Mar 21, 2024 · filing
- Form 8-K · items 3.01 · filed Feb 29, 2024 · filing
- Form SC 13D · filed Feb 14, 2024 · filing
- Form 10-Q · filed Nov 14, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Nov 9, 2023 · filing
- Form 8-K · items 5.02 · filed Oct 17, 2023 · filing
- Form 10-Q · filed Aug 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Aug 10, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed May 11, 2023 · filing
- Form 10-Q · filed May 11, 2023 · filing
- Form 10-K · filed Mar 24, 2023 · filing
- Form 8-K · items 2.02, 9.01 · filed Mar 21, 2023 · filing